# Editorial Comment on “Risk Assessment of Cytomegalovirus Reactivation After Kidney Transplantation Under a Universal Preemptive Strategy in the Era of Intravenous Immunoglobulin‐Based Desensitization Therapy”

**Authors:** Tomoaki Yamanoi, Motoo Araki

PMC · DOI: 10.1111/iju.70410 · International Journal of Urology · 2026-03-17

## Full-text entities

- **Diseases:** CMV (MESH:D003586), toxicities (MESH:D064420), CMV reactivation (MESH:D000085343), opportunistic complication (MESH:D009894)
- **Chemicals:** RIT (MESH:D000069283)
- **Species:** Homo sapiens (human, species) [taxon 9606], Cytomegalovirus (genus) [taxon 10358]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12994313/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12994313/full.md

---
Source: https://tomesphere.com/paper/PMC12994313